Synaptophysin Protein

Synaptophysin Protein

Introduction

Synaptophysin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@masliah1989]
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptophysin</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Synaptophysin</td></tr>
<tr><td><strong>Gene</strong></td><td>[SYP](/genes/syp)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P08247](https://www.uniprot.org/uniprot/P08247)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>313 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~38 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicle membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Synaptophysin family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Epilepsy, Schizophrenia</td></tr>
</table>
</div>

Overview

...

Synaptophysin Protein

Introduction

Synaptophysin Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@masliah1989]
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptophysin</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Synaptophysin</td></tr>
<tr><td><strong>Gene</strong></td><td>[SYP](/genes/syp)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P08247](https://www.uniprot.org/uniprot/P08247)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>313 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~38 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Synaptic vesicle membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Synaptophysin family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Epilepsy, Schizophrenia</td></tr>
</table>
</div>

Overview

Synaptophysin (encoded by the SYP gene) is the most abundant integral membrane protein of synaptic vesicles, constituting approximately 6-8% of total synaptic vesicle protein content. As a founding member of the synaptophysin family, this protein serves as the gold standard marker for synaptic density and has been extensively utilized in neuropathology studies of neurodegenerative diseases[@wiedenmann1985]. Its universal presence in virtually all synaptic terminals makes it invaluable for assessing synaptic integrity in conditions ranging from Alzheimer's disease to epilepsy[@masliah1989].

Structure

Primary Structure

• Length: 313 amino acids
• Molecular weight: Approximately 38 kDa
• Transmembrane domains: 4 hydrophobic regions

Topology

• N-terminus: Cytoplasmic, contains phosphorylation sites
• Transmembrane regions: Four transmembrane helices
• C-terminus: Cytoplasmic, interacts with synaptic proteins

Quaternary Structure

• Forms hexameric or heptameric channels
• Creates a pore-like structure in synaptic vesicle membrane
• Can form homo-oligomers

Post-Translational Modifications

• Phosphorylation: Multiple serine residues (PKA, CaMKII sites)
• Glycosylation: N-linked glycosylation in extracellular loops
• Palmitoylation: Acyl chain modifications for membrane association

Molecular Function

Synaptic Vesicle Biology

As the major synaptic vesicle protein, synaptophysin participates in:

Vesicle Biogenesis

• Critical for synaptic vesicle formation
• Involved in vesicle maturation
• Organizes vesicle protein composition

Vesicle Trafficking

• Modulates synaptic vesicle recycling
• Regulates endocytosis and exocytosis
• Controls vesicle pool dynamics

Protein Interactions

SNARE Complex

• Synaptobrevin-2/VAMP2: Direct interaction in SNARE complex
• Syntaxin-1: Partner in synaptic fusion machinery
• SNAP-25: Completes the SNARE complex

Calcium Sensing

• Synaptotagmin-1: Calcium sensor for release
• Coordinates fusion machinery with calcium influx

Other Partners

• CSPα/DNAJC5: Chaperone for synaptic proteins
• Hsc70: Heat shock protein involvement
• AP-2: Clathrin adaptor in endocytosis

Normal Function in the Nervous System

Synaptic Transmission

Synaptophysin is essential for normal synaptic function:

Vesicle organization: Maintains synaptic vesicle pools

Release modulation: Regulates neurotransmitter release probability

Plasticity: Contributes to short-term and long-term plasticity

Homeostasis: Adapts to changing neural activity

Brain Region Distribution

• Universal presynaptic marker across all brain regions
• Highest density in: cerebral cortex, hippocampus, cerebellum
• Expressed in both excitatory and inhibitory [neurons](/entities/neurons)

Role in Neurodegenerative Diseases

Alzheimer's Disease

Synaptophysin loss is a hallmark of AD:

• [Hippocampus](/brain-regions/hippocampus): 30-50% reduction in AD vs. controls
• [Cortex](/brain-regions/cortex): 20-40% reduction correlating with cognitive decline
• [Entorhinal cortex](/brain-regions/entorhinal-cortex): Earliest synaptic loss in prodromal AD

Correlations:

• Cognitive scores: MMSE, CDR correlations
• Amyloid burden: Inverse correlation with plaque load
• [Tau](/proteins/tau) pathology: Correlates with neurofibrillary tangles
• Disease progression: MCI → AD transition marker[^3]

Parkinson's Disease

In PD and Lewy body diseases:

• Loss of cortical synaptophysin in PD with dementia
• Correlation with cognitive impairment severity
• Early marker of terminal dysfunction
• Dopaminergic terminal vulnerability

Epilepsy

• Altered expression in epileptic foci
• Marker of excitatory/inhibitory imbalance
• Surgical target identification

Schizophrenia

• Reduced synaptophysin in prefrontal cortex
• Evidence for synaptic pathology
• Correlates with cognitive deficits

Therapeutic Implications

Biomarker Applications

CSF Biomarker

• Measures synaptic degeneration
• Monitors disease progression
• Treatment response biomarker

Neuroimaging

• PET ligands for synaptic density (SV2A as proxy)
• Correlates with cognitive function

Drug Development

Gene Therapy

• SYP promoter-driven therapeutic expression
• Viral vector approaches

Neuroprotective Strategies

• Preserve synaptic terminals
• Enhance synaptic function
• Prevent synaptic loss

Research Directions

Biomarker validation: CSF synaptophysin clinical utility

Imaging: PET synaptic density ligands

Mechanism: Precise role in vesicle cycling

Therapy: Gene and cell-based approaches

Models: Transgenic and knockout studies

Animal Models

• SYP knockout: Viable, subtle synaptic deficits
• SYP overexpression: Enhanced plasticity and memory
• AD models: Correlation with amyloid pathology

See Also

• [SYP Gene](/syp-gene)
• [Synapsin I Protein](/proteins/synapsin-i-protein)
• [Synapsin II Protein](/proteins/synapsin-2)
• [Synaphin Protein](/proteins/synaphin-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [SV2A Protein](/biomarkers/sv2a-synaptic-vesicle-protein)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)

External Links

• [UniProt: P08247](https://www.uniprot.org/uniprot/P08247)
• [NCBI Protein: SYP](https://www.ncbi.nlm.nih.gov/protein/NP_003167.2)
• [PDB: 1JX3](https://www.rcsb.org/structure/1JX3)
• [Allen Brain Atlas: SYP](https://human.brain-map.org/microarray/search/show?search_term=SYP)

Background

The study of Synaptophysin Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Wiedenmann B, Franke WW, Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles (1985)

Masliah E, Terry RD, DeTeresa R, Hansen LA, Immunohistochemical quantification of the synaptic marker synaptophysin in Alzheimer disease (1989)